Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways, leading to repeateted episodes of breathlessness, wheezing and labored breathing.Breathing exercises help to manage hyperventilation often seen in asthmatic patients. To handle respiratory complications asthmatics are advised to practise nasal breathing techniques in conjunction with their prescribed medications.
Adults: aged (18-45 years)
Gender: Both males and females
Grade1- Grade 4 on Modified MRC dyspnea scale
Asthma severity classes (intermediate, mild persistent and moderate persistent asthma) acc. to NAEPP national asthma education and prevention program guidlin
Patients having acute exacerbation of COPD or status asthmaticus
Patients diagnosed with acute infections
Patients unable to follow command/ instructions
Asthma patients with >40 sec control pause duration
Parallel
Alternative nostril breathing
Other interventionPatients in this group will receive alternative nostril breathing along with pharmacological management. For alternative nostirl breathing patient will be advised to inhale slowly (4sec) and deeply through left nostril.Then hold breath for 2-3 sec. Release right nostril and use right ring finger to close left nostril. Exhale slowly (6sec) and completely through right nostril. Inhale slowly (4sec) and deeply through right nostril. Then hold breath for 2-3sec. Release left nostril and use right thumb to close right nostril. Exhale slowly (6sec) and completely through left nostril. Repeat the cycle.
Pharmacological therapy
DrugParticipants in this group will only be provided with standard pharmacological management for 4 weeks as prescribed by a pulmonologist. For example: Salbutamol inhaler (Short acting bronchodilator) Saltra inhaler (Selective long acting β2 adrenoceptor agonist) Tiotropium (Anticholinergic) Combivir (Nucleoside analogue - reverse transcriptase inhibitor) etc. Week 01 and week 02: Patients will receive medication prescribed by pulmonologist. Week 03 and week 04: Patients will receive medication prescribed by pulmonologist.
Dyspnea
Evaluation will be done using Dyspnea-12 questionnaire for dyspnea
Control pause
Stopwatch will be used to measure control pause.
Asthma control
Asthma control test (ACT) will be used to evaluate asthma control and peak flow meter for peak expiratory flow rate.
Peak expiratory flow rate.
Peak flow meter will be used to measure peak expiratory flow rate
Click on the lead sponsor to view all of their trials.
